Drug Profile
Research programme: oral biotherapeutics - Precigen Inc
Alternative Names: AG015; Antibody-toxin conjugates - Precigen Inc; Clostridium difficile enteropathy therapeutic - Precigen Inc; Clostridium difficile-associated enterocolitis therapeutic - Precigen Inc; IL-10/proinsulin ActoBiotics™; IL-27 - Precigen Inc; Inflammatory bowel disease ActoBiotics™; Inflammatory bowel disease therapeutics - Precigen Inc; Interleukin-27 - Precigen Inc; Lactococcus lactis expressing human interleukin-27; Lactococcus lactis secreting human interleukin-27; Microbiome ActoBiotics™; Microbiome modulators - Precigen Inc; Microbiota ActoBiotics™; Microbiota modulators - Precigen Inc; Peptide-toxin conjugates - Precigen IncLatest Information Update: 28 Nov 2022
Price :
$50
*
At a glance
- Originator ActoGeniX
- Developer Intrexon Corporation; Precigen Inc; Theriva Biologics
- Class Anti-inflammatories; Antigens; Antihyperglycaemics; Bacteria; Cytokines; Hormones; Monoclonal antibodies; Peptides; Recombinant proteins; Small molecules
- Mechanism of Action Bacterial toxin inhibitors; Enzyme replacements; Helper-inducer T-lymphocyte modulators; Immunomodulators; Immunosuppressants; Interleukin 27 replacements; Microbiome modulators; Tumour necrosis factor alpha inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Coeliac disease; Type 1 diabetes mellitus
Highest Development Phases
- No development reported Digestive system disorders; Inflammatory bowel diseases; Non-alcoholic steatohepatitis; Phenylketonuria; Type 2 diabetes mellitus
- Discontinued Clostridium difficile infections
Most Recent Events
- 28 Nov 2022 No recent reports of development identified for preclinical development in Non-alcoholic-steatohepatitis in USA (PO)
- 12 Oct 2022 Synthetic Biologics is now called Theriva Biologics
- 28 Mar 2022 No recent reports of development identified for preclinical development in Inflammatory-bowel-diseases in Belgium (PO, Capsule)